Meta-analiz: Türk Toplumunda MTHFR c.677C>T polimorfizmi ve kanser ilişkisi

Cilt: 51 Sayı: 4 1 Aralık 2012
  • Çetintaş V B
  • Avcı Ç B
  • Süslüer S Y
  • Eroğlu Z
  • Gündüz C
Ege Tıp Dergisi Kapak
Ege Tıp Dergisi
PDF İndir
EN TR

Meta-analysis: Association between MTHFR c.677C>T polymorphism and cancer in the Turkish population

Abstract

Global DNA hypomethylation associates with hyperhomocysteinemia, MTHFR c.677C>T homozygosity and the development of cancer. Aim: The aim of this study was to investigate the relationship of the MTHFR c.677C>T polymorphism with the risk of cancer in the Turkish population via meta-analysis. Materials and Methods: Studies were identified by searching electronic literature, focusing on the key words; Turkish population, MTHFR C677T and the risk of cancer. All data were analyzed using STATA software. Odds ratio (OR) and 95% confidence interval (Cl) values were calculated using the Mantel-Haentzel statistic according to fixed-effect model. Results: Odds ratio values for Recessive (CC+CT vs TT), Homozygous (CC vs TT) and Dominant (CC vs CT+TT) genetic models were calculated as 1.24 (95% CI: 1.013-1.524), 1.14 (95% CI: 0.93-1.41) and 0.97 (95% CI: 0.869-1.090), respectively. The risk of cancer increased significantly in the TT genotype (p=0.043). Conclusion: Our results support the finding that MTHFR c.677C>T polymorphism is a potential biomarker for cancer risk in the Turkish population.

Keywords

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Çetintaş V B

Avcı Ç B

Süslüer S Y

Eroğlu Z

Gündüz C

Yayımlanma Tarihi

1 Aralık 2012

Gönderilme Tarihi

1 Aralık 2012

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2012 Cilt: 51 Sayı: 4

IZ

https://izlik.org/JA65WE44HX

Kaynak Göster

RIS / Bibtex
Vancouver
1.Çetintaş V B, Avcı Ç B, Süslüer S Y, Eroğlu Z, Gündüz C. Meta-analiz: Türk Toplumunda MTHFR c.677C>T polimorfizmi ve kanser ilişkisi. ETD [Internet]. 01 Aralık 2012;51(4):221-8. Erişim adresi: https://izlik.org/JA65WE44HX

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.